3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
16
Breast Neoplasms
7
Urinary Bladder Neoplasms
4
Lung Neoplasms
4
Colorectal Neoplasms
4
Ovarian Neoplasms
3
Testicular Neoplasms
2
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Prostate Adenocarcinoma
1
Pancreatic Neoplasms
1
Overweight
1
Obesity
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Lymphoma
1
Kidney Neoplasms
1
Health Behavior
1
Erectile Dysfunction
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Breast Neoplasms, Male
1
Anxiety Disorders
1
Interventions
Gemcitabine
30
Mitomycin
25
BCG Vaccine
13
Docetaxel
10
Epirubicin
6
erdafitinib
5
durvalumab
5
dodecyl maltoside
5
Radiotherapy
5
Cystoscopy
5
apaziquone
4
ALT-803
4
tislelizumab
3
5-aminolevulinic acid hexyl ester
3
viscum album peptide
2
pembrolizumab
2
disitamab vedotin
2
avelumab
2
VB4-845
2
Therapeutics
2
Imiquimod
2
Hyaluronic Acid
2
Administration, Intravesical
2
1-phenyl-3,3-dimethyltriazene
2
vocimagene amiretrorepvec
1
valrubicin
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Educational Status
×
Genitourinary
×
Clear all
NCT05154084
2023-11-14
RESECT
British Urology Researchers in Surgical Training
Completed
19,505 enrolled